Oncology MRI

For biopsy-naïve patients who had radical prostatectomy for prostate cancer, new research suggests that biparametric MRI is comparable to multiparametric MRI for detecting extraprostatic extension.

A model combining MRI and ultrasound findings yielded a 93 percent AUC for predicting microvascular invasion in hepatocellular carcinoma.

Researchers said the combination of 18F-flotufolastat PET/MRI may lead to a 57 percent reduction of prostate biopsies in comparison to a 25 percent reduction with prostate MRI alone.

In comparison to everolimus, the peptide receptor radionuclide therapy (177Lu)Lu-edotreotide provided over a nine month longer median progression-free survival for patients with gastroenteropancreatic neuroendocrine tumours (GEP NETs), according to new phase 3 research.

In comparison to the 2009 International Federation of Gynecology and Obstetrics (FIGO) staging system for endometrial cancer, researchers found that the updated 2023 FIGO system had over a 17 percent decrease for substage agreement between pelvic MRI and pathology findings.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in June 2026.

Catch up on a variety of FDA news in radiology from the past week.

For men with high clinical risk for prostate cancer (PCa) and a lack of significant findings on mpMRI, triage use of PSMA PET/CT resulted in a 49 percent reduction of biopsies and an 18 percent reduction in detection of clinically insignificant PCa, according to newly published research.

Catch up on a variety of new FDA clearances in radiology from the past week.

The MIM Contour ProtegeAI+ 2.0 software reportedly offers new AI-powered contouring models for brain MRIs and pelvic CTs.

Catch up on the top radiology content of the past week.

Catch up on the most-well viewed radiology content in May 2026.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in May 2026.

In recent interviews, Emanuel Kanal, MD, and Tobias Gilk, MRSO, MRSE, discuss new multicenter research examining pediatric MRI safety as well as key challenges and preventive measures in this patient population.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

In a study of 351 women with BI-RADS 3-5 non-mass enhancement breast lesions, researchers found that multiparametric MRI offered 98.4 percent sensitivity and a 97.9 percent negative predictive value (NPV).

Catch up on a variety of new FDA clearances in radiology from the past week.

Prostate AI reportedly enhances lesion detection, reduces segmentation variability between radiologists and improves workflow efficiencies in biopsy-recommended cases.

In a new meta-analysis examining the impact of MRI-based AI models for predicting high-grade hepatocellular carcinoma, researchers noted a 10 percent decline in AUC between internal validation and external validation.

The combination of sustained high-gradient performance and AI capabilities with the Titanion MR may facilitate the use of imaging biomarkers that provide insight into tissue microstructure

Cystadenomas and cystadenofibromas accounted for 46 percent of benign lesions initially scored as O-RADS 4 and 5 lesions on pelvic ultrasound, according to newly published research.

Catch up on the top radiology content of the past week.

In a recent interview with Diagnostic Imaging, Soroush Adam Ramin, MD, discussed the enhanced 3D visualization and prognostic capability of Unfold AI, an MRI-based software platform that was recently added to Medicare Physician Fee Schedules for the West Coast and Mountain West regions.

In a recent interview with Diagnostic Imaging, Wendie Berg, MD, PhD, shared her perspective on various aspects of the controversial breast cancer screening guidance issued by the American College of Physicians (ACP), including the use of supplemental imaging in women with dense breasts.